Skip to main content

  • Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis

    • Posted: 01/31/2021
    • Author:

      Michael Megaly, Matthew Glogoza, Iosif Xenogiannis, Evangelia Vemmou, Ilias Nikolakopoulos, Mohamed Omer, Laura Willson, David J. Monyak, Patsa Sullivan, Larissa Stanberry, Ivan Chavez, Michael Mooney, Jay Traverse, Yale Wang, Santiago Garcia, Anil Poulose, M. Nicholas Burke, Emmanouil S. Brilakis

    • CRM2021

    Abstract

    Background

    Recurrent drug-eluting stents (DES) in-stent restenosis (ISR) can be challenging to treat. The combined use of excimer laser atherectomy (ELCA) and vascular brachytherapy (VBT) for this indication has received limited study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details